Back to results
TerminatedPhase 2Phase 3

Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's Disease

NCT00040404

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Barrow Neurological Institute

Phoenix, Arizona, United States

+65 additional locations

View on ClinicalTrials.gov
Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's Disease — TrialFind